Lude Zhu

Shanghai, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Exploration of the roles of CAFs in melanoma based on single-cell transcriptomics and spatial transcriptomics.

Exploration of the roles of CAFs in melanoma based on single-cell transcriptomics and spatial transcriptomics.

Journal: Discover oncology
Published: June 29, 2025

Plum-blossom needle tapping enhances the efficacy of ALA photodynamic therapy for facial actinic keratosis in Chinese population: a randomized, multicenter, prospective, and observer-blind study.

Plum-blossom needle tapping enhances the efficacy of ALA photodynamic therapy for facial actinic keratosis in Chinese population: a randomized, multicenter, prospective, and observer-blind study.

Journal: Photodiagnosis and photodynamic therapy
Published: February 09, 2023

Single-cell transcriptomic analysis reveals the critical molecular pattern of UV-induced cutaneous squamous cell carcinoma.

Single-cell transcriptomic analysis reveals the critical molecular pattern of UV-induced cutaneous squamous cell carcinoma.

Journal: Cell death & disease
Published: July 14, 2021

5-Aminolevulinic acid photodynamic therapy for early-stage lip squamous cell carcinoma.

5-Aminolevulinic acid photodynamic therapy for early-stage lip squamous cell carcinoma.

Journal: Photodiagnosis and photodynamic therapy
Published: January 01, 2021

CCL8 enhances sensitivity of cutaneous squamous cell carcinoma to photodynamic therapy by recruiting M1 macrophages.

CCL8 enhances sensitivity of cutaneous squamous cell carcinoma to photodynamic therapy by recruiting M1 macrophages.

Journal: Photodiagnosis and photodynamic therapy
Published: January 30, 2019

The effect of C-X-C motif chemokine ligand 13 in cutaneous squamous cell carcinoma treated with aminolevulinic acid-photodynamic therapy.

The effect of C-X-C motif chemokine ligand 13 in cutaneous squamous cell carcinoma treated with aminolevulinic acid-photodynamic therapy.

Journal: Photodiagnosis and photodynamic therapy
Published: January 23, 2019

Comparison of efficacy, adverse effects and costs between 20 % ALA-PDT and 10 % ALA-PDT for the treatment of actinic keratosis in Chinese patients.

Comparison of efficacy, adverse effects and costs between 20 % ALA-PDT and 10 % ALA-PDT for the treatment of actinic keratosis in Chinese patients.

Journal: Photodiagnosis and photodynamic therapy
Published: January 18, 2019

Conventional versus daylight photodynamic therapy for actinic keratosis: A randomized and prospective study in China.

Conventional versus daylight photodynamic therapy for actinic keratosis: A randomized and prospective study in China.

Journal: Photodiagnosis and photodynamic therapy
Published: July 31, 2018

Analysis of KIT mutations in five patients from two Han Chinese pedigrees affected with Piebaldism

Analysis of KIT mutations in five patients from two Han Chinese pedigrees affected with Piebaldism

Journal: Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
Published: June 14, 2018

Therapeutic effect of Imiquimod enhanced ALA-PDT on cutaneous squamous cell carcinoma.

Therapeutic effect of Imiquimod enhanced ALA-PDT on cutaneous squamous cell carcinoma.

Journal: Photodiagnosis and photodynamic therapy
Published: June 01, 2018

Analysis of clinical and genetic features of nine patients with disseminated superfacial actinic porokeratosis

Analysis of clinical and genetic features of nine patients with disseminated superfacial actinic porokeratosis

Journal: Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
Published: August 05, 2017

Clinical and Molecular Characterization of NF1 Patients: Single-Center Experience of 32 Patients From China.

Clinical and Molecular Characterization of NF1 Patients: Single-Center Experience of 32 Patients From China.

Journal: Medicine
Published: March 11, 2016
Showing 1-12 of 14

Last Updated: 09/26/2026